Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy response
Guangdong Academy of Medical Sciences · Guangdong Provincial People's Hospital · +11 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
215
total citations
- FWCI
- 33.23
- Percentile
- 100%
- References
- 62
Citations per year
Authors
26- YMYan MeiCorresponding
Guangdong Academy of Medical Sciences, Guangdong Provincial People's Hospital, State Key Laboratory of Respiratory Disease, Southern Medical University, Guangzhou Medical University
- XWXiumei Wang
Sun Yat-sen University
- JZJi Zhang
Sun Yat-sen University, Sun Yat-sen University Cancer Center
- DLDan Liu
Xuzhou Medical College
- JHJunjie He
Xuzhou Medical College, State Key Laboratory of Respiratory Disease, Guangzhou Medical University
Topics & keywords
Topics
Keywords
- Cancer research
- Immunotherapy
- Immune checkpoint
- Immune system
- CD8
- T cell
- Blockade
- Chemokine
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.